Editing Malignancy (section)

====Post-transplant malignancy====
Individuals who undergo organ transplant surgery have an increased risk of developing malignancy in comparison to the general population.<ref name = "Rossi_2018" /> The most common form of malignancy being "[[nonmelanoma skin cancer]] and, posttransplant [[lymphoproliferative disorders]]".<ref name = "Rossi_2018" /> The different types of malignancy developed post-transplant depend on which organ was transplanted.<ref name = "Collett_2010">{{cite journal | vauthors = Collett D, Mumford L, Banner NR, Neuberger J, Watson C | title = Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit | journal = American Journal of Transplantation | volume = 10 | issue = 8 | pages = 1889–1896 | date = August 2010 | pmid = 20659094 | doi = 10.1111/j.1600-6143.2010.03181.x | s2cid = 40192165 | doi-access = free }}</ref> This is linked to recipients being at a higher risk when exposed to traditional risk factors as well as, the type and intensity of the operation, the duration of their [[immunosuppression]] post-operation and, the risk of developing oncogenic viral infections.<ref name = "Rossi_2018" />